PRDM14 siRNA therapy(The University of Tokyo)

N/A

Report date: 2024/06/26 15:58:29
NME

Base Information

Drug NamePRDM14 siRNA therapy(The University of Tokyo)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionPR Domain Zinc Finger Protein 14 inhibitors
TargetsPR Domain Zinc Finger Protein 14
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Tokyo
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Tokyo
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A